New heart stent aims to cut blood thinner time, lower bleeding risk

NCT ID NCT06412250

Recruiting now Disease control Sponsor: Translumina Therapeutics Pvt Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is tracking 2,000 heart disease patients who receive the VIVO ISAR stent, a drug-coated device that releases medication to keep arteries open. Participants will take blood thinners for three months or less after the procedure. Researchers are monitoring for heart attacks, stent clots, and major bleeding to see if this shorter treatment is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: VIVO ISAR polymer-free sirolimus-eluting coronary stent
What this could lead to: If successful, this could show that the VIVO ISAR stent is safe and effective with a shorter course of blood thinners, potentially reducing bleeding risks for heart disease patients.
What could go wrong: This is an observational registry, not a controlled trial, so results may be influenced by patient selection. The short blood thinner regimen may increase the risk of stent-related blood clots or heart attacks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES

Contacts and locations

Show contact details

Locations

ASREM - Regional Hospitals
RECRUITING

Campobasso, 86100, Italy
Adesh Hospital
RECRUITING

Bathinda, 151001, India
Amsterdam UMC (University Medical Centers)
RECRUITING

Amsterdam, 91105, Netherlands
Bedford Hospital
RECRUITING

Bedford, MK42 9DJ, United Kingdom
Clinica Mediterranea
RECRUITING

Naples, 80122, Italy
Clinica Pierangeli
RECRUITING

Pescara, 65124, Italy
Derriford Hospitalm Plymouth NHS Trust
RECRUITING

Plymouth, PL6 8DH, United Kingdom
Dr. Ram Manohar Lohia Hospital (RML)
RECRUITING

Lucknow, 226010, India
Fortis
RECRUITING

Mohali, 160062, India
Fortis Escorts Heart Institute & Research Centre
RECRUITING

Delhi, 110025, India
Fortis Escorts Heart Institute & Research Centre
RECRUITING

Delhi, 110025, India
Fortis Hospital
RECRUITING

Bangalore, 560076, India
Fortis Hospital
RECRUITING

Kalyān, 421301, India
Fortis Hospital
RECRUITING

Kolkata, 700107, India
Freeman Hospital
RECRUITING

Newcastle, NE7 7DN, United Kingdom
L.P.S Institute of Cardiology
RECRUITING

Kanpur, 208019, India
Medanta-The Medicity
RECRUITING

Gurugram, 122001, India
Montevergine
RECRUITING

Mercogliano AV, 83013, Italy
National Heart Institute
RECRUITING

Delhi, 11 00 65, India
PGIMER
RECRUITING

Chandigarh, 160012, India
Salisbury NHS Foundation Trust
RECRUITING

Salisbury, SP2 8BJ, United Kingdom
Santo Spirito Hospital
RECRUITING

Pescara, 65124, Italy
Seva Sadan Hospital
RECRUITING

Miraj, 416410, India

Contact Email: •••••@•••••
Shalby Hospital
RECRUITING

Jabalpur, 482002, India
Tergooi MC
RECRUITING

Hilversum, 1213 XZ, Netherlands
Tor Vergata University
RECRUITING

Roma, 00133, Italy
University of Padua, Padova
RECRUITING

Padova, 35122, Italy
Viecuri MC
RECRUITING

Venlo, 5912, Netherlands
Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust
RECRUITING

Wigan, WN1 2NN, United Kingdom
Yashoda Hospitals
RECRUITING

Hyderabad, 500081, India
Yashodha Hospital
RECRUITING

Somājigūda, 500082, India
Zydus Hospitals
RECRUITING

Ahmedabad, 380054, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.